Industry News
Boron Molecular completes capital raising, considers IPO
Boron Molecular, a small Melbourne-based medicinal chemistry company, is planning to pursue listing on the Australian Stock Exchange in the next six months if market conditions are favourable, according to managing director Dr Phillip Reese. [ + ]
Stem cell centre swings into action as funding finally approved
Activities at the National Stem Cell Centre were delayed by an inquiry into allegations that it was given preferential treatment during bidding for Commonwealth funding, the centre's chief operating officer, Dr Dianna DeVore, said today, but Prime Minister John Howard's December 24 announcement that an independent report found no basis to the allegations was "a wonderful Christmas present". [ + ]
Gene technology to be used in carp control plan
The Murray-Darling Basin Commission is to back a radical new attempt to control Australia's worst aquatic pest, the carp. [ + ]
Peptech reaps $10m from share placement
Sydney-based biotechnology company Peptech Limited today announced it has raised $AUD10 million in new capital by placing 6,625,000 shares with several major institutions, including AMP, ING Australia and the Escor Group. [ + ]
Door opens for Ventracor clinical trials
Ventracor has gained approval from the Alfred Hospital's Ethics Committee, paving the way for the first clinical trial of its VentrAssist artificial heart device to begin. [ + ]
US billionaire offers $25m to Melbourne institutes
US billionaire and fairy godfather Charles Feeney has offered Melbourne's Royal Children's Hospital and the Murdoch Children's Research Institute $AUD25 million to build new laboratories and clinical research facilities. [ + ]
Solar cells could put power stations in space
Scientists at Rochester Institute of Technology in the US are developing the next generation of solar cells, advancing the technology that could put a solar power system into earth's orbit.
[ + ]Autogen eyes global market after capital raising
Melbourne-based biotech Autogen plans to spend the proceeds of a $AUD6.65 million capital raising on expanding globally, including upgrading a level 1 American Depositary Receipt (ADR) Nasdaq listing to a level 2 ADR listing during the coming year and actively seeking new partners and possible acquisitions. [ + ]
Greenpeace to step up fight against GM canola in Australia
Greenpeace Australia Pacific has signalled that it will step up its campaign to block the introduction of genetically modified canola into Australia, by advertising for a new anti-GM campaigner. [ + ]
Scale-up problems force layoffs at Ambri
Listed biotech Ambri Ltd has laid off 15 staff in response to unexpected manufacturing problems in scaling up its biosensor technology for commercial production. [ + ]
Computer program reveals optimum microstructure
A Princeton chemist has developed a general mathematical system for designing materials that perform two functions at once, even when the desired properties sometimes conflict with each other.
[ + ]World-first Australian truffle find
An Australian scientist has made a discovery which is electrifying world fungal biology - a new truffle genus related to the famous Amanita family, or fairy toadstools.
[ + ]International grants for water research
A senior UNSW researcher is part of an international science collaboration, funded jointly by the European Union and the Australian Government under the Innovation Access (International Science and Technology) program, to study drinking water risk management.
[ + ]Happy holidays from all of us
Australian Biotechnology News will be closed for the holidays, until January 6, 2003. [ + ]
Research points the whey forward for milk
Milk is the first food that any mammal tastes, a fluid perfectly formulated by nature for the nutritional and developmental needs of newborn mammals. [ + ]